Evolving Effect of the COVID-19 Pandemic on Cancer-Related Encounters.
Jack W LondonElnara Fazio-EynullayevaMatvey B PalchukChristopher M McNairPublished in: JCO clinical cancer informatics (2022)
Although the number of COVID-19 cases fluctuated, the steep declines observed during March and April 2020 in screening for breast and colon cancer and patients with newly diagnosed cancer did not continue through the rest of 2020 and into April 2021. Screening and new incidence cancer numbers quickly rose compared with prepandemic levels. The concern that more patients with advanced-stage cancer would be seen in the months following the drastic dips of March-April 2020 was not realized as the major disruption to normal cancer care was limited to these 2 months.